Related Experiment Video
Updated: Jul 15, 2025

Caspase-3 Activity in the Rat Amygdala Measured by Spectrofluorometry After Myocardial Infarction
Published on: January 12, 2016
The Possible Role of NLRP3 Inflammasome in Depression and Myocardial Infarction Comorbidity
Erensu Baysak1, Cagan Yildirim2, Nurten Sayar2
1Department of Psychiatry, School of Medicine, Marmara University, Istanbul 34854, Turkey.
Insights
The NOD-like receptor protein 3 (NLRP3) inflammasome pathway may contribute to depression in myocardial infarction patients. Higher NLRP3 levels were linked to an increased likelihood of depression, warranting further investigation.
Area of Science:
- Cardiovascular Medicine
- Psychiatry
- Immunology
Background:
- Cardiovascular disease and depression frequently co-occur.
- The role of inflammation, specifically the NLRP3 inflammasome pathway and hsCRP, in this comorbidity is not fully understood.
Purpose of the Study:
- To investigate the association between the NLRP3 inflammasome pathway, hsCRP, and depression in patients with incident myocardial infarction.
- To determine if NLRP3 inflammasome pathway activation is linked to depression in myocardial infarction patients.
Main Methods:
- Sixty-eight patients with ST-elevation myocardial infarction and twenty healthy controls were enrolled.
- Patients were assessed for depression using the Structured Clinical Interview for DSM-5 Disorders-Clinician Version.
- Levels of NLRP3, IL-18, IL-1β, and hsCRP were measured using ELISA.
Main Results:
- Myocardial infarction patients exhibited significantly higher levels of NLRP3, IL-1β, IL-18, and hsCRP compared to healthy controls.
- No significant differences in these markers were observed between myocardial infarction patients with and without depression.
- Logistic regression revealed that NLRP3 levels significantly predicted the likelihood of depression in myocardial infarction patients (OR = 1.72, CI = 1.11-2.66).
Conclusions:
- While direct differences in NLRP3 pathway markers were not found between depressed and non-depressed myocardial infarction patients, NLRP3 activation is associated with an increased likelihood of depression.
- The NLRP3 inflammasome pathway may play a role in the development of depression in the context of myocardial infarction.
- Further research with larger sample sizes is recommended to confirm these findings.
Abstract:
It is well-established that cardiovascular disease and depression are highly comorbid. This study aimed to assess the possible role of the NOD-like receptor protein 3 (NLRP3) inflammasome pathway and the high-sensitivity C-reactive protein (hsCRP) in patients with incident myocardial infarction in the presence or absence of depression. Sixty-eight consecutive patients with incident ST-elevation myocardial infarction and twenty healthy subjects were included. The patients were assessed using the Structured Clinical Interview for DSM-5 Disorders-Clinician Version during their 1-4-day-long hospitalization and were divided into two groups: with and without comorbid depression. Blood samples for the determination of NLRP3, interleukin-18 (IL-18), interleukin-1β (IL-1β), and hsCRP levels were analyzed using ELISA. NLRP3, IL-1β, IL-18, and hsCRP levels were significantly higher in myocardial infarction patients compared to the healthy group (p = 0.02, p < 0.001, p < 0.001, and p < 0.001, respectively). No significant difference was found between the myocardial groups with and without depression. However, in the logistic regression analysis, the NLRP3 variable in myocardial infarction patients was found to have a significant contribution to the likelihood of depression (p = 0.015, OR = 1.72, and CI = 1.11-2.66). The likelihood of depression is associated with increasing NLRP3 levels in myocardial infarction patients. However, this potential role should be further explored in a larger sample.
More Related Videos
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Regulation of the Unfolded Protein Response
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis III: Medical Management
Rheumatic Heart Disease I: Introduction
Long-term Depression

